1 (Translation) MD. 083/2019 May 8, 2019 Re: Management Discussion and Analysis For the Operating Results ended March 31, 2019 To: President The Stock Exchange of Thailand Management Discussion and

ที่บชง Page 1 of 4 Ref. Bor Chor Ngor 0268/2020 10 August 2020 Subject: Management Discussion and Analysis for the Second Quarter ended 30 June 2020 To President The Stock Exchange of Thailand

, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting

Provision for Employee Benefit 379.97 2.26 365.94 2.26 14.03 3.83 Advance Received for Rental Income from Associate 93.54 0.56 99.43 0.62 (5.89) (5.92) GFPT Public Company Limited Interim Management

E_1 Legal_FA_2015_12_29-c A CCoorrppLL44..11hhiigg A Executive Summary Management Discussion and Analysis For the Quarter Ended June 30, 2017 The global economy in the second quarter of 2017

Practice Guidelines No. NorPor. 4/2559 Re: Practical Guidelines for Business Continuity Management _______________________________ Reference is made to the notification of the Capital Market Supervisory

Guidelines No. NorPor. 4/2559 Re: Practical Guidelines for Business Continuity Management _______________________________ Reference is made to the notification of the Capital Market Supervisory Board No

., Km. 39.5 Bangpoomai, Amphur Muang Samutprakarn, Samutprakarn 10280, Thailand Tel. 66 2323 1085..96 Fax. 66 2323 9283 (Translation) 20 February 2019 Subject: Management Discussion and Analysis (MD&A) of

., Km. 39.5 Bangpoomai, Amphur Muang Samutprakarn, Samutprakarn 10280, Thailand Tel. 66 2323 1085..96 Fax. 66 2323 9283 23 February 2018 Subject: Management Discussion and Analysis (MD&A) of the year 2017

hereunder: “intermediary” means a securities company or a derivatives intermediary. “fund management company” means a securities company licensed to undertake securities business in the category of mutual